Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking

Annals of Surgical Oncology

Volumn 18, Issue 9, 2011, Pages 2629-2637

  Fotopoulou, Christina ^a   Richter, Rolf ^a   Braicu, Elena Ioana ^a   Kuhberg, Marc ^a   Feldheiser, Aarne ^a   Schefold, Joerg C ^a   Lichtenegger, Werner ^a   Sehouli, Jalid ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER PATIENT; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MORBIDITY; OBESITY; OPERATION DURATION; OVARY CANCER; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OBESITY; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052738105     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1637-z     Document Type: Article

References (31)

1. RE Bristow 2000 Surgical standards in the management of ovarian cancer (review) Curr Opin Oncol. 12 474 480 10975556 10.1097/00001622-200009000-00015 1:STN:280:DC%2BD3M%2FmsVWgtQ%3D%3D (Pubitemid 32268886)
2. du Bois A, Quinn M, Thigpen T, et al.; Gynecologic Cancer Intergroup; AGO-OVAR; ANZGOG; EORTC; GEICO; GINECO; GOG; JGOG; MRC/NCRI; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG; IGCS; Organizational team of the two prior International OCCC. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd international gynecologic cancer intergroup ovarian cCancer consensus conference (GCIG OCCC 2004). Ann Oncol. 2005;16(Suppl 8):viii7-viii12. (Pubitemid 41631227)
3. HS Scholz H Tasdemir T Hunlich W Turnwald A Both H Egger 2007 Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: results and 5-year follow-up Gynecol Oncol. 106 591 595 17619055 10.1016/j.ygyno.2007.05.023 (Pubitemid 47302481)
4. DS Chi CC Franklin DA Levine, et al. 2004 Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol Oncol. 94 650 654 15350354 10.1016/j.ygyno.2004.01.029 (Pubitemid 39194456)
5. A du Bois A Reuss E Pujade-Lauraine P Harter I Ray-Coquard J Pfisterer 2009 Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) Cancer 115 1234 1244 19189349 10.1002/cncr.24149
6. O Zivanovic EL Eisenhauer Q Zhou, et al. 2008 The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer Gynecol Oncol. 108 287 292 17996927 10.1016/j.ygyno.2007.10.001 (Pubitemid 351174284)
7. GD Aletti SC Dowdy BS Gostout, et al. 2009 Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience J Am Coll Surg. 208 614 620 19476798 10.1016/j.jamcollsurg.2009.01.006
8. RJ Hunter MA Navo PH Thaker DC Bodurka JK Wolf JA Smith 2009 Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA) Cancer Treat Rev. 35 69 78 18922643 10.1016/j.ctrv.2008.07.005 1:CAS:528:DC%2BD1MXhtlSmuro%3D
9. AJ Canchola ET Chang L Bernstein, et al. 2010 Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort Cancer Causes Control. 21 2241 2248 20924664 10.1007/s10552-010-9647-x
10. D Sharma J Wang PP Fu, et al. 2010 Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis Hepatology. 52 1713 1722 20941777 10.1002/hep.23892 1:CAS:528:DC%2BC3cXhsFOnsrvN
11. LE Winfree MS Henretta PT Hallowell SC Modesitt 2010 Pre-operative gynecologic evaluation of bariatric surgery patients: improving cancer detection in a high-risk population J Am Coll Surg. 211 256 262 20670865 10.1016/j.jamcollsurg.2010.03.011
12. GM McCawley JS Ferriss D Geffel CJ Northup SC Modesitt 2009 Cancer in obese women: potential protective impact of bariatric surgery J Am Coll Surg. 208 1093 1098 19476897 10.1016/j.jamcollsurg.2009.01.045
13. World Health Organization. Obesity. http://www.who.int/topics/obesity/en.
14. International Federation of Gynecology and Obstetrics 1987 Changing in definitions of clinical staging for carcinoma of the cervix and ovary Am J Obstet Gynecol. 156 263 264
15. JD Douketis PB Berger AS Dunn, et al. 2008 American College of Chest Physicians. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 6 Suppl 299S 339S 18574269 10.1378/chest.08-0675 1:CAS:528:DC%2BD1cXptVKhsrw%3D (Pubitemid 351894915)
16. J Sehouli D Könsgen A Mustea, et al. 2003 "IMO"- intraoperative mapping of ovarian cancer Zentralbl Gynakol. 125 129 135 12961105 10.1055/s-2003-41864 1:STN:280:DC%2BD3svitFaksQ%3D%3D (Pubitemid 37047280)
17. J Sehouli F Senyuva C Fotopoulou, et al. 2009 Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer J Surg Oncol. 99 424 427 19365809 10.1002/jso.21288
18. C Fotopoulou R Richter EI Braicu SC Schmidt W Lichtenegger J Sehouli 2010 Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients Eur J Surg Oncol. 36 1202 1210 20864305 1:STN:280:DC%2BC3cblt1KqtQ%3D%3D
19. EE Calle C Rodriguez K Walker-Thurmond MJ Thun 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults N Engl J Med. 348 1625 1638 12711737 10.1056/NEJMoa021423 (Pubitemid 36459468)
20. NK Saxena L Taliaferro-Smith BB Knight, et al. 2008 Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor Cancer Res. 68 9712 9722 19047149 10.1158/0008-5472.CAN- 08-1952 1:CAS:528:DC%2BD1cXhsVegtbvJ
21. S Uddin R Bu M Ahmed, et al. 2009 Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer Mol Cancer. 8 74 19765303 10.1186/1476-4598-8-74
22. KS Matthews JM Straughn Jr MK Kemper KE Hoskins W Wang RP Rocconi 2009 The effect of obesity on survival in patients with ovarian cancer Gynecol Oncol. 112 389 393 19062080 10.1016/j.ygyno.2008.10.016
23. F Vernooij P Heintz E Witteveen Y van der Graaf 2007 The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review Gynecol Oncol. 105 801 812 17433422 10.1016/j.ygyno.2007.02.030 (Pubitemid 46734206)
24. T Paulsen K Kjaerheim J Kaern S Tretli C Tropé 2006 Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals Int J Gynecol Cancer 16 Suppl 1 11 17 16515561 10.1111/j.1525-1438.2006.00319.x
25. MC Salman A Usubutun T Ozlu K Boynukalin K Yuce 2010 Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers J Gynecol Oncol. 21 24 28 20379444 10.3802/jgo.2010.21.1.24
26. Doyle SL, Lysaght J, Reynolds JV. Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev. 2009 Dec 16.
27. C Fotopoulou A duBois AN Karavas, et al. 2008 Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel- containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group J Clin Oncol. 26 2683 2689 18509180 10.1200/JCO.2008.16.1109 1:CAS:528: DC%2BD1cXnvVOhsLY%3D
28. Übergewicht (Adipositas). http://www.blikk.it/angebote/modellmathe/ ma0675.htm.
29. SV Barrett J Paul A Hay PA Vasey SB Kaye 2008 Glasspool RM; Scottish Gynaecological Cancer Trials Group. Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial Ann Oncol 19 898 902 18272913 10.1093/annonc/mdm606 1:STN:280: DC%2BD1c3nvFalsg%3D%3D (Pubitemid 351627304)
30. JC Pavelka RS Brown BY Karlan, et al. 2006 Effect of obesity on survival in epithelial ovarian cancer Cancer. 107 1520 1524 16941453 10.1002/cncr.22194 (Pubitemid 44546912)
31. I Skírnisdóttir B Sorbe 2008 Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early-stage epithelial ovarian cancer Int J Gynecol Cancer. 18 345 351 17587318 10.1111/j.1525-1438.2007.01013.x (Pubitemid 351365212)